Phosphorus is associated with coronary artery disease in patients with preserved renal function.
Phosphorus is associated with coronary artery disease in patients with preserved renal function.
复制标题
磷与肾功能保留的患者的冠状动脉疾病有关。
DOI:
10.1371/journal.pone.0036883
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Moysés RM
中科院分区:
文献类型:
--
作者:
Cancela AL;Santos RD;Titan SM;Goldenstein PT;Rochitte CE;Lemos PA;dos Reis LM;Graciolli FG;Jorgetti V;Moysés RM
High serum phosphorus levels have been associated with mortality and cardiovascular events in patients with chronic kidney disease and in the general population. In addition, high phosphorus levels have been shown to induce vascular calcification and endothelial dysfunction in vitro. The aim of this study was to evaluate the relation of phosphorus and coronary calcification and atherosclerosis in the setting of normal renal function. This was a cross-sectional study involving 290 patients with suspected coronary artery disease and undergoing elective coronary angiography, with a creatinine clearance >60 ml/min/1.73 m2. Coronary artery obstruction was assessed by the Friesinger score and coronary artery calcification by multislice computed tomography. Serum phosphorus was higher in patients with an Agatston score >10 than in those with an Agatston score ≤10 (3.63±0.55 versus 3.49±0.52 mg/dl; p = 0.02). In the patients with Friesinger scores >4, serum phosphorus was higher (3.6±0.5 versus 3.5±0.6 mg/dl, p = 0.04) and median intact fibroblast growth factor 23 was lower (40.3 pg/ml versus 45.7 pg/ml, p = 0.01). Each 0.1-mg/dl higher serum phosphate was associated with a 7.4% higher odds of having a Friesinger score >4 (p = 0.03) and a 6.1% greater risk of having an Agatston score >10 (p = 0.01). Fibroblast growth factor 23 was a negative predictor of Friesinger score (p = 0.002). In conclusion, phosphorus is positively associated with coronary artery calcification and obstruction in patients with suspected coronary artery disease and preserved renal function.
登录
查看更多内容
DOI:
10.1056/nejmoa0706130
发表时间:
2008-08-07
期刊:
The New England journal of medicine
影响因子:
--
作者:
Gutiérrez OM;Mannstadt M;Isakova T;Rauh-Hain JA;Tamez H;Shah A;Smith K;Lee H;Thadhani R;Jüppner H;Wolf M
通讯作者:
Wolf M
影响因子:
5.3
作者:
Onufrak, Stephen J.;Bellasi, Antonio;Raggi, Paolo
通讯作者:
Raggi, Paolo
影响因子:
6.1
作者:
Mirza, Majd A. I.;Hansen, Tomas;Larsson, Tobias E.
通讯作者:
Larsson, Tobias E.
影响因子:
6.8
作者:
Rasouli, M;Kiasari, AM
通讯作者:
Kiasari, AM
影响因子:
39.2
作者:
Parker BD;Schurgers LJ;Brandenburg VM;Christenson RH;Vermeer C;Ketteler M;Shlipak MG;Whooley MA;Ix JH
通讯作者:
Ix JH